Dendritic cells in intestinal immune regulation

Nature Reviews Immunology

Volumn 8, Issue 6, 2008, Pages 435-446

  Coombes, Janine L ^a   Powrie, Fiona ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; RETINOL;

ANTIGEN PRESENTING CELL; CELL FUNCTION; DENDRITIC CELL; ENTERITIS; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INTESTINE CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INTESTINES;

EID: 44349167059     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2335     Document Type: Review

References (119)

1. Iwasaki, A. Mucosal dendritic cells. Annu. Rev. Immunol. 25, 381-418 (2007).
2. Smith, P. D., Ochsenbauer-Jambor, C. & Smythies, L. E. Intestinal macrophages: unique effector cells of the innate immune system. Immunol. Rev. 206, 149-159 (2005).
3. Johansson, C. & Kelsall, B. L. Phenotype and function of intestinal dendritic cells. Semin. Immunol. 17, 284-294 (2005).
4. Iwasaki, A. & Kelsall, B. L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239 (1999).
5. Chirdo, F. G., Millington, O. R., Beacock-Sharp, H. & Mowat, A. M. Immunomodulatory dendritic cells in intestinal lamina propria. Eur. J. Immunol. 35, 1831-1840 (2005).
6. +, and double-negative Peyer's patch dendritic cells. J. Immunol. 166, 4884-4890 (2001).
7. Annacker, O., et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202, 1051-1061 (2005).
8. Iwasaki, A. & Kelsall, B. L. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3α, MIP-3β, and secondary lymphoid organ chemokine. J. Exp. Med. 191, 1381-1394 (2000).
9. Smythies, L. E., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75 (2005).
10. Denning, T. L., Wang, Y. C., Patel, S. R., Williams, I. R. & Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nature Immunol. 8, 1086-1094 (2007).
11. Naik, S. H., et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nature Immunol. 7, 663-671 (2006).
12. Wilson, N. S., et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102, 2187-2194 (2003).
13. Fogg, D. K., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83-87 (2006).
14. Varol, C., et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204, 171-180 (2007).
15. Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
16. Yrlid, U., Jenkins, C. D. & MacPherson, G. G. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J. Immunol. 176, 4155-4162 (2006).
17. Yoshida, M., et al. Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity 20, 769-783 (2004).
18. Jang, M. H., et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl Acad. Sci. USA 101, 6110-6115 (2004).
19. Rescigno, M., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol. 2, 361-367 (2001).
20. Chieppa, M., Rescigno, M., Huang, A. Y. & Germain, R. N. Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203, 2841-2852 (2006).
21. 3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254-258 (2005).
22. Turnbull, E. L., Yrlid, U., Jenkins, C. D. & Macpherson, G. G. Intestinal dendritic cell subsets: differential effects of systemic TLR4 stimulation on migratory fate and activation in vivo. J. Immunol. 174, 1374-1384 (2005).
23. Wilson, N. S., et al. Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol. Cell Biol. 86, 200-205 (2008).
24. Macpherson, A. J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665 (2004).
25. Huang, F. P., et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435-444 (2000).
26. Worbs, T., et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 203, 519-527 (2006).
27. Jiang, A., et al. Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity 27, 610-624 (2007). This study provided details of a distinctive programme of DC maturation initiated by disruption of E-cadherin-mediated DC-DC interactions.
28. Wendland, M., et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl Acad. Sci. USA 104, 6347-6352 (2007).
29. Yrlid, U., et al. Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-α and type 1 IFNs after feeding a TLR7/8 ligand. J. Immunol. 176, 5205-5212 (2006).
30. Sun, C. M., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
31. Mucida, D., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 (2007).
32. - precursors. Blood 110, 4293-4302 (2007).
33. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
34. + T cells. This was found to be mediated in part by retinoic acid, which enhanced TGFβ-mediated induction of FOXP3.
35. + dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202, 1063-1073 (2005).
36. 8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365 (2007). This study provided physiological evidence that DCs, through the activation of TGFβ, can influence intestinal immune homeostasis.
37. Lacy-Hulbert, A., et al. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc. Natl Acad. Sci. USA 104, 15823-15828 (2007).
38. + regulatory T cells. J. Exp. Med. 201, 737-746 (2005).
39. + DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 108, 481-492 (2003).
40. 7 integrin. Eur. J. Immunol. 32, 1445-1454 (2002).
41. Johansson-Lindbom, B., et al. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant. J. Exp. Med. 198, 963-969 (2003).
42. Mora, J. R., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424, 88-93 (2003).
43. Briskin, M., et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151, 97-110 (1997).
44. Kunkel, E. J., et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192, 761-768 (2000).
45. + regulatory T cell homing. Eur. J. Immunol. 37, 978-989 (2007).
46. Macpherson, A. J. & Slack, E. The functional interactions of commensal bacteria with intestinal secretory IgA. Curr. Opin. Gastroenterol. 23, 673-678 (2007).
47. Martinoli, C., Chiavelli, A. & Rescigno, M. Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity 27, 975-984 (2007).
48. + Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J. Immunol. 171, 3684-3690 (2003).
49. 2 class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826 (2007).
50. Cerutti, A. The regulation of IgA class switching. Nature Rev. Immunol. 8, 421-434 (2008).
51. Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774 (2007).
52. Schambach, F., Schupp, M., Lazar, M. A. & Reiner, S. L. Activation of retinoic acid receptor-α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37, 2396-2399 (2007).
53. Iwata, M., et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527-538 (2004).
54. Mora, J. R., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314, 1157-1160 (2006). This study showed that gut-associated lymphoid tissue DCs could promote expression of gut-homing receptors by B cells. This was mediated by retinoic acid. Retinoic acid also synergized with IL-5 and IL-6 to promote secretion of IgA.
55. McDermott, M. R., et al. Impaired intestinal localization of mesenteric lymphoblasts associated with vitamin A deficiency and protein-calorie malnutrition. Immunology 45, 1-5 (1982).
56. Stephensen, C. B. Vitamin A, infection, and immune function. Annu. Rev. Nutr. 21, 167-192 (2001).
57. Elias, K. M., et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-1020 (2008).
58. Blomhoff, R. & Blomhoff, H. K. Overview of retinoid metabolism and function. J. Neurobiol. 66, 606-630 (2006).
59. Saurer, L., McCullough, K. C. & Summerfield, A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J. Immunol. 179, 3504-3514 (2007).
60. Lampen, A., Meyer, S., Arnhold, T. & Nau, H. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J. Pharmacol. Exp. Ther. 295, 979-985 (2000).
61. + T cells. Mucosal Immunol. 1, 38-48 (2008).
62. Cantorna, M. T., Nashold, F. E. & Hayes, C. E. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J. Immunol. 152, 1515-1522 (1994).
63. Sidell, N., Chang, B. & Bhatti, L. Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes. Cell. Immunol. 146, 28-37 (1993).
64. Rincon, M. & Flavell, R. A. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13, 4370-4381 (1994).
65. Wu, Y., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006).
66. Schule, R., et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl Acad. Sci. USA 88, 6092-6096 (1991).
67. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
68. Artis, D. Epithelial-cell recognition of commensal flora and maintenance of immune homeostasis in the gut. Nature Rev. Immunol. 8, 411-421 (2008).
69. H2-type responses. This effect was in part mediated by TSLP.
70. H2-type responses following Trichuris muris infection.
71. + regulatory T cells in human thymus. Nature 436, 1181-1185 (2005).
72. Szatmari, I., et al. PPARγ controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 203, 2351-2362 (2006).
73. Kobayashi, M., et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111, 1297-1308 (2003).
74. Takeda, K., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39-49 (1999).
75. Butler, M., et al. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur. J. Immunol. 36, 864-874 (2006).
76. Rakoff-Nahoum, S., Hao, L. & Medzhitov, R. Role of Toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25, 319-329 (2006).
77. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
78. Contractor, N., Louten, J., Kim, L., Biron, C. A. & Kelsall, B. L. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFβ, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 179, 2690-2694 (2007).
79. Rimoldi, M., et al. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106, 2818-2826 (2005).
80. Sierro, F., et al. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl Acad. Sci. USA 98, 13722-13727 (2001).
81. Nenci, A., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446, 557-561 (2007).
82. Becker, C., et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112, 693-706 (2003).
83. Salazar-Gonzalez, R. M., et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 24, 623-632 (2006). This study revealed that T-cell activation following Salmonella spp. infection was dependent on the recruitment of CCR6-expressing DCs to the follicle-associated epithelium of the Peyer's patches.
84. H17 and regulatory T cells. Nature 441, 235-238 (2006).
85. Hart, A. L., et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129, 50-65 (2005).
86. Uhlig, H. H., et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
87. Berndt, B. E., Zhang, M., Chen, G. H., Huffnagle, G. B. & Kao, J. Y. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J. Immunol. 179, 6255-6262 (2007).
88. Abe, K., et al. Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proc. Natl Acad. Sci. USA 104, 17022-17027 (2007).
89. Watanabe, N., et al. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis. Sci. 48, 408-414 (2003).
90. Strober, W., Murray, P. J., Kitani, A. & Watanabe, T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Rev. Immunol. 6, 9-20 (2006).
91. Inohara, N., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278, 5509-5512 (2003).
92. Li, J., et al. Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations Hum. Mol. Genet. 13, 1715-1725 (2004).
93. Uehara, A., et al. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7, 53-61 (2005).
94. Netea, M. G., et al. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J. Immunol. 174, 6518-6523 (2005).
95. van Heel, D. A., et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365, 1794-1796 (2005).
96. van Beelen, A. J., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27, 660-669 (2007).
97. Happel, K. I., et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
98. + T helper cells. Cell 126, 1121-1133 (2006).
99. H17 lineage. Nature 441, 231-234 (2006).
100. Kobayashi, K. S., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734 (2005).
101. Watanabe, T., et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118, 545-559 (2008).
102. Watanabe, T., Kitani, A., Murray, P. J. & Strober, W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunol. 5, 800-808 (2004).
103. Maeda, S., et al. Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307, 734-738 (2005).
104. Duerr, R. H., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
105. Yen, D., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316 (2006).
106. Hue, S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203, 2473-2483 (2006).
107. Kullberg, M. C., et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203, 2485-2494 (2006).
108. Izcue, A., et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28, 559-570 (2008).
109. Sugimoto, K., et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008).
110. Jang, M. H., et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176, 803-810 (2006).
111. Karlis, J., et al. Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm. Bowel Dis. 10, 834-847 (2004).
112. Liu, L. M. & MacPherson, G. G. Rat intestinal dendritic cells: immunostimulatory potency and phenotypic characterization. Immunology 85, 88-93 (1995).
113. Kilshaw, P. J. Expression of the mucosal T cell integrin αM290 β7 by a major subpopulation of dendritic cells in mice. Eur. J. Immunol. 23, 3365-3368 (1993).
114. Brenan, M. & Puklavec, M. The MRC OX-62 antigen: a useful marker in the purification of rat veiled cells with the biochemical properties of an integrin. J. Exp. Med. 175, 1457-1465 (1992).
115. Asselin-Paturel, C., Brizard, G., Pin, J. J., Briere, F. & Trinchieri, G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171, 6466-6477 (2003).
116. Yrlid, U., et al. Plasmacytoid dendritic cells do not migrate in intestinal or hepatic lymph. J. Immunol. 177, 6115-6121 (2006).
117. Balmer, J. E. & Blomhoff, R. Gene expression regulation by retinoic acid. J. Lipid Res. 43, 1773-1808 (2002).
118. La, P., et al. Fusion proteins of retinoid receptors antagonize TGF-β-induced growth inhibition of lung epithelial cells. Oncogene 22, 198-210 (2003).
119. Pendaries, V., Verrecchia, F., Michel, S. & Mauviel, A. Retinoic acid receptors interfere with the TGF-β/Smad signaling pathway in a ligand-specific manner. Oncogene 22, 8212-8220 (2003)